The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...

The Madras High Court has recently allowed an appeal by Ab Initio Technology LLC, a US-based company, against the Patent ...

The Indian Patent Office's decision to cancel the patent for Novartis's major heart drug, Vymada, has added a new chapter to ...

Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S ...

New policies rolled out by the U.S. patent office polices may make it harder for lower-cost medicines to reach consumers, ...

The patent world is at a moment of change. The incentives for obtaining and aggressively monetizing patents are increasing.

WIPO's new Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge would impose additional ...

These innovations took us from shabby offices with quill pens to today’s high-tech environments.

As data analysis becomes a bigger focus in the medtech industry, protecting approach methodology is supplanting patent ...

This year’s Nobel Prize in economics went to Joel Mokyr, Philippe Aghion, and Peter Howitt for their research on how ...